rheumatoid arthritis 2
DESCRIPTION
Rawalpindi Medical collegeTRANSCRIPT
![Page 1: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/1.jpg)
Rheumatoid ArthritisProf. Dr. M.Shoaib ShafiFCPS (Pak) FCPS (Bangladesh) FACP (USA)FRCP (London) FRCP (Edin) FRCP (Ire) FRCP (Glasgow)Professor of Medicine, Rawalpindi Medical CollegeCouncillor and Vice President, College of Physicians and Surgeons Pakistan
![Page 2: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/2.jpg)
•Is a lifelong progressive disease that produces significant morbidity, and premature mortality in some
•50% have to stop work after 10yrs
![Page 3: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/3.jpg)
Epidemiology
•May present at any age
•Commonly, late child bearing age in females, and 6th-8th decade in males
•Female: Male 3:1 difference diminishes in old age.•Affects 1% of population
![Page 4: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/4.jpg)
Pathology
•Symmetrical deforming polyarthropathy, affecting the synovial membrane of peripheral joints
•Has a genetic component, but many do not have a FHx
![Page 5: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/5.jpg)
![Page 6: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/6.jpg)
Presentation •May have a fulminant onset, but
commonly insidious over weeks to months•Classically small joints initially – PIP’s,
MCP’s, MTP’s•Pain, swelling, stiffness – esp early
morning •Can affect any synovial joint - may involve
TMJ, cricoarytenoids, or SCJ’s•Spares DIP’s (cf OA & psoriatic arthritis)•May involve C1-2 articulation – rarely
affects the rest of the spine
![Page 7: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/7.jpg)
O/E• Early -> boggy warm joints in typical distribution• Hands – ulnar devation, swan neck & boutoniere’s
deformity, tendon rupture• Wrists – radial devation, volar subluxation,
synovial proliferation may compress median nerve• Feet – sublux at MTP’s, skin ulceration, painful
ambulation• Large joints – affects whole joint surface in
symmetrical fashion eg med & lat compartment of knees
• Synovial cysts eg Baker’s cyst of the knee, ganglions
![Page 8: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/8.jpg)
![Page 9: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/9.jpg)
![Page 10: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/10.jpg)
![Page 11: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/11.jpg)
![Page 12: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/12.jpg)
Extra –articular manifestationsCommon: • Fatigue, wt loss, low grade fever• Subcutaneous nodules;
▫ almost exclusively sero-positive pt’s▫ thought to be triggered by small vessel vasculitis
• Carpel & tarsal tunnel syndromes• Capsulitis eg shoulder• Increased mortality & morbidity from CVS disease if have RhA
Uncommon:• vasculitis• Pyoderma gangrenosum• Pericardial effusions• Pulmonary effusions• Diffuse interstitial fibrosis• Scleritis • Mononeuritis multiplex• C1-2 -> myelopathy
![Page 13: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/13.jpg)
Bloods
•Anaemia of chronic disease•ESR + CRP ^ - acute phase reactants
▫CRP is more specific than ESR▫Not always ^ in small joint disease
•RhF - +ve in 50%
•Include U+E’s, LFT’s pre-DMARD use
![Page 14: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/14.jpg)
•Anti-cyclic citrullinated peptide (anti-CCP) and anti-mutated citrullinated vimentin (anti-MCV) assay.
![Page 15: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/15.jpg)
Radiology
•Xray hands (include wrists) and feet•Loss of joint space•Soft tissue swelling•Erosions – particularly look 5th MC & MT
& ulnar styloid, & scaphoid/trapezium•Peri-articular osteoporosis•Joint destruction
![Page 16: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/16.jpg)
![Page 17: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/17.jpg)
![Page 18: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/18.jpg)
![Page 19: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/19.jpg)
![Page 20: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/20.jpg)
![Page 21: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/21.jpg)
Differential Diagnosis• Viral syndromes – hep B or C, EBV, parvovirus, rubella• Psoriatic arthritis• Reactive arthritis• Enteropathic arthritis• Tophaceous gout• Ca pyrophoshate disease (pseudogout)• PMR• OA• SLE• Hypothroid association• Sarcoidosis• Lyme disease• Rheumatic fever
![Page 22: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/22.jpg)
Diagnosis
•Distribution of joint involvement•Morning stiffness•Active synovitis. Inflammation (swelling,
warmth, or both) on examination•Symptoms for > 6 weeks•RhF, ESR, CRP
![Page 23: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/23.jpg)
Diagnosis (American College of Rheumatology)•Morning stiffness*•Arthritis of 3 joint areas*•Arthritis of hands*•Symmetric arthritis*•Sero +ve•Radiological changes•* for greater than 6 weeks
![Page 24: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/24.jpg)
Who to refer
•>12w•3 or more joints•Skin rash - ? vascultis
![Page 25: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/25.jpg)
Treatment
•To relieve pain & inflammation
•Prevent joint destruction
•Preserve / improve function
![Page 26: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/26.jpg)
Treatment
•Early diagnosis is essential•Aim to treat with DMARD’s at 3 months•Once RA damage is done radiologically, it
is largely irreversible. This usually occurs within first 2 years of the disease
•The goal is to put the disease into remission
![Page 27: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/27.jpg)
MDT
•GP•Rheumatologist•Specialist rheumatology nurses + help
line•Physio + hydrotherapy•OT•Pharmacist •Phlebotomist
![Page 28: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/28.jpg)
NSAID’s
•Symptom relief•Minimal role in altering disease process
![Page 29: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/29.jpg)
Gluccocorticoids
•Symptom relief•Some slowing of radiological progression•Prednisolone > 10mg/d is rarely indicated•Avoid using without a DMARD•Use to bridge effective DMARD therapy•Minimise duration and dose•Always consider osteoporosis prophylaxis
![Page 30: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/30.jpg)
Methotrexate • Oral 7.5mg - ^ by 2.5mg every 6w to max 25mg.
ONCE WEEKLY (allows liver to recover)• Is an anti-metabolite, cytotoxic drug, which
inhibs DNA synthesis & cellular replication• Lower dose in elderly & renal impairment as its
renally excreted• Folic acid (3d after methotrexate) thought to
decrease toxicity• Avoid cotrimoxazole, trimethoprim, XS ETOH,
live vaccines• Give annual flu jab• Can be given subcut if oral absorption poor
![Page 31: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/31.jpg)
Methotrexate cont…..
•SE’s: oral ulcers, nausea, hepatotoxicity, bone marrow suppression, pneumonitis
•All respond to dose reduction except pneumonitis
•Stop 3/12 before pregnancy – remember males
•Pre-Rx: FBC, U+E, LFT, CXR, Pt education•Monitoring:
▫every 2/52 for 1st 2/12. ▫ then every 1/12
![Page 32: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/32.jpg)
Methotrexate • Withhold and d/w rheumatologist if;
▫ WBC < 4▫ Neuts <2▫ Plts< 150▫ > x2 ^ AST, ALT▫ Unexplained low albumin▫ Rash or oral ulcers▫ New or ^ing dyspnoea
• Ix if MCV > 105 (B12/ Folate)• Deterioration in renal func – decease dose• Abnormal bruising or sore throat – stop and
check FBC
![Page 33: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/33.jpg)
Sulfasalazine / Salazopyrine
•500mg/day - ^ by 500mg weekly to 2-3g/d•Pre-Rx: FBC, LFT, U+E•Monitor:
▫FBC, LFT every 2/52 for 8/52 ▫then 1/12 for 10/12▫Then every 3/12 after 1y’s treatment
•Stop and d/w rheumatologist as indicated before
•Headaches, dizziness, nausea – decrease dose
![Page 34: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/34.jpg)
Hydroxychloroquine •Least toxic•Is an anti-malarial•Yearly optician review – retinal toxicity•200-400mg/d•Often used in combo with other DMARD’s•Check U+E prior to starting•Avoid in eye related maculopathy,
diabetes or other significant eye disease•Consider stopping after 5 years•Yearly bloods
![Page 35: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/35.jpg)
Leflunomide (Arava)•100mg for 3 days, then 20mg/d, can
decrease to 10mg/d•2nd line treatment. Is a new drug.•Should not be used with other DMARD’s•May inhibit metab of warfarin, phenytoin,
tolbutamide•Long elimination half life – so may react
with other DMARD’s even after stopping it
•Must not procreate within 2y of stopping. Do serum levels.
![Page 36: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/36.jpg)
Leflunomide cont…..• SE’s: blood dyscrasias, hepatotoxicity, mouth
ulcers, skin rash (inc stevens-johnson & toxic epidermal necrolysis), mild ^BP, GI upset, wt loss, headaches, dizziness, tenosynovitis, hair loss.
• If severe SE’s – elim with cholestyramine 8g or activated charcoal
• Pre-Rx: FBC, U+E, LFT, BP• Monitor: FBC, LFT, U+E, BP
▫ Every 2/52 for 6/12▫ Then every 8/52
• Withhold as above
![Page 37: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/37.jpg)
Azathioprine• 1mg/kg/d - ^ after 4-6/52 to 2-3mg/kg/d• Immunosuppressant, antiproliferative, inhibits
DNA synthesis• Lower dose in hepatic or renal impairment• If on allopurinol cut dose by 25%• Avoid live vaccines• Give pneumovax and flu jab• Passive immunisation for varicella zoster in non-
immune pts if exposed to chicken pox or shingles• Pre-Rx: FBC, U+E, LFT• Monitor:
▫ Every 2/52 for 2/12 & after every dose change▫ Then every 1/12
![Page 38: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/38.jpg)
Gold / Sodium Aurothiomalate (Myocrisin)•10mg im test dose (done in clinic) then
20mg, then weekly 50mg to dose of 1g – then reassess
•Pre-Rx: FBC, U+E, LFT, urinalysis•Monitor:
▫FBC and urinalysis at each injection▫Results to be available at next dose▫Each time ask about oral ulcers & rashes
•Withhold as above
![Page 39: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/39.jpg)
Penicillamine Rarely used!
![Page 40: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/40.jpg)
Cyclosporin •Is an immunosuppressant•2.5mg/kg/d in 2 divided doses. ^ after
4/52 by 25mg to max 4mg/kg/d•Avoid in renal impairment or uncontrolled
BP•Numerous drug interactions -> BNF•Need to ½ dose of diclofenac•Avoid colchine & nifedipine•Use k-sparing diuretics with care•Avoid grapefruit juice & live vaccines
![Page 41: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/41.jpg)
•Pre-Rx: FBC, U+E X2, LFT, lipids, BP X2, 24 hour creatinine clearance
•Monitor: FBC, LFT, ESR, BP▫2/52 till on stable dose for 3/12 ▫Then 1/12▫LFT’s every 1/12 until on stable dose for 3/12 then
every 3/12▫Serum lipids every 6/12 – 1 year
•Withhold and d/w rheumatologist; ^ by 30% of baseline creat Anormal bruising ^K ^BP
^lipids Plts < 150 >X2 ^ of AST, ALT, ALP
![Page 42: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/42.jpg)
Anti-TNF alpha• Use for highly active RhA in adults who have
failed at least 2 DMARD’s, including methotrexate
• Etanercept 25mg subcut twice a week• Infliximab 3-10mg/kg iv every 4-8 weeks• Adalimumab 40mg subcut alternate weeks• Rapid onset (days to weeks)• Disadvantages: cost & unknown long term
effects, infections, demyelinating syndromes• Should be given with methotrexate• High risk atypical infections – low threshold for
abx prophylaxis
![Page 43: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/43.jpg)
IL-1 receptor antagonist
•Not commonly used yet!•Anakinra 100mg/d subcut•In combo with methotrexate•Slower onset than anti-TNF•SE; injection site reactions, pneumonia
(esp in elderly with asthma)
![Page 44: Rheumatoid arthritis 2](https://reader033.vdocuments.us/reader033/viewer/2022061115/54636320af7959477b8b5379/html5/thumbnails/44.jpg)
Conclusion
•RhA is a lifelong dx•Ideally want an early diagnosis•MDT + pt education•Effective new drugs •Safe monitoring (pt + MDT responsibility)